Last Updated: August 2, 2026

Organon Usa Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ORGANON USA INC

ORGANON USA INC has nineteen approved drugs.

There is one tentative approval on ORGANON USA INC drugs.

Summary for Organon Usa Inc

US Patents:	0
Tradenames:	18
Ingredients:	18
NDAs:	19

Drugs and US Patents for Organon Usa Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Usa Inc	CALDEROL	calcifediol	CAPSULE;ORAL	018312-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	ORGATRAX	hydroxyzine hydrochloride	INJECTABLE;INJECTION	087014-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	PAVULON	pancuronium bromide	INJECTABLE;INJECTION	017015-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	METHYLPREDNISOLONE	methylprednisolone sodium succinate	INJECTABLE;INJECTION	087535-002	Jun 25, 1982		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-002	Mar 17, 1994		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	PAVULON	pancuronium bromide	INJECTABLE;INJECTION	017015-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Start Trial				⤷ Start Trial
Organon Usa Inc	RAPLON	rapacuronium bromide	INJECTABLE;INJECTION	020984-001	Aug 18, 1999		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Organon Usa Inc

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-002	Apr 30, 1984	4,237,126	⤷ Start Trial
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-003	Jan 3, 1992	4,297,351	⤷ Start Trial
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-003	Jan 3, 1992	4,237,126	⤷ Start Trial
Organon Usa Inc	CALDEROL	calcifediol	CAPSULE;ORAL	018312-001	Approved Prior to Jan 1, 1982	3,565,924	⤷ Start Trial
Organon Usa Inc	PAVULON	pancuronium bromide	INJECTABLE;INJECTION	017015-002	Approved Prior to Jan 1, 1982	3,553,212	⤷ Start Trial
Organon Usa Inc	NORCURON	vecuronium bromide	INJECTABLE;INJECTION	018776-002	Apr 30, 1984	4,297,351	⤷ Start Trial
Organon Usa Inc	RAPLON	rapacuronium bromide	INJECTABLE;INJECTION	020984-002	Aug 18, 1999	5,418,226	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.